Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-11 7:02 pm Purchase | 2026-06-02 | 13G | ZAI LAB LTD ZLAB | TCG Crossover GP II, LLC | 59,130,750 5.300% | 59,130,750 (New Position) | Filing History |
| 2026-05-15 4:26 pm Purchase | 2026-03-31 | 13G | LB PHARMACEUTICALS INC LBRX | TCG Crossover GP II, LLC | 1,839,489 6.400% | 94,474 (+5.41%) | Filing History |
| 2026-05-15 4:26 pm Purchase | 2026-03-31 | 13G | FULCRUM THERAPEUTICS INC FULC | TCG Crossover GP II, LLC | 5,250,000 7.900% | 250,000 (+5.00%) | Filing History |
| 2026-05-15 4:26 pm Purchase | 2026-03-31 | 13G | VISTAGEN THERAPEUTICS INC VTGN | TCG Crossover GP II, LLC | 4,100,029 9.990% | 1,397,872 (+51.73%) | Filing History |
| 2026-05-15 4:25 pm Purchase | 2026-03-31 | 13G | SURROZEN INC SRZN | TCG Crossover GP II, LLC | 1,473,101 12.700% | 199,091 (+15.63%) | Filing History |
| 2026-05-15 4:24 pm Sale | 2026-03-31 | 13G | TANGO THERAPEUTICS INC TNGX | TCG Crossover GP II, LLC | 11,597,737 8.100% | -1,924,102 (-14.23%) | Filing History |
| 2026-05-15 4:24 pm Purchase | 2026-03-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | TCG Crossover GP II, LLC | 4,622,151 5.500% | 194,446 (+4.39%) | Filing History |
| 2026-05-12 6:09 pm Purchase | 2026-05-05 | 13G | AVALO THERAPEUTICS INC PAR AVTX | TCG Crossover GP II, LLC | 3,017,120 7.900% | 3,017,120 (New Position) | Filing History |
| 2026-05-12 6:06 pm Purchase | 2026-05-05 | 13G | AURA BIOSCIENCES INC AURA | TCG Crossover GP II, LLC | 9,533,333 9.900% | 9,533,333 (New Position) | Filing History |
| 2026-05-01 4:36 pm Purchase | 2026-04-24 | 13G | ALTIMMUNE INC ALT | TCG Crossover GP II, LLC | 20,000,000 9.800% | 20,000,000 (New Position) | Filing History |
| 2026-04-01 5:29 pm Purchase | 2026-03-30 | 13G | VOR BIOPHARMA INC VOR | TCG Crossover GP II, LLC | 5,673,078 10.500% | 5,673,078 (New Position) | Filing History |
| 2026-02-27 5:17 pm Purchase | 2026-02-12 | 13G | TECTONIC THERAPEUTIC INC TECX | TCG Crossover GP II, LLC | 1,169,760 6.200% | 1,169,760 (New Position) | Filing History |
| 2026-02-17 4:26 pm Purchase | 2025-10-27 | 13G | ADC THERAPEUTICS SA SHS ADCT | TCG Crossover GP II, LLC | 11,390,175 9.200% | 11,390,175 (New Position) | Filing History |
| 2026-02-17 4:25 pm Unchanged | 2025-12-31 | 13G | EYEPOINT INC EYPT | TCG Crossover GP II, LLC | 3,572,335 4.300% | 0 (Unchanged) | Filing History |
| 2026-02-17 4:22 pm Purchase | 2025-12-31 | 13G | TANGO THERAPEUTICS INC TNGX | TCG Crossover GP II, LLC | 13,521,839 9.990% | 4,985,643 (+58.41%) | Filing History |
| 2026-02-17 4:22 pm Purchase | 2025-12-31 | 13G | AMYLYX PHARMACEUTICALS INC AMLX | TCG Crossover GP II, LLC | 6,243,812 5.700% | 1,600,000 (+34.45%) | Filing History |
| 2026-02-06 4:45 pm Purchase | 2026-02-03 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | TCG Crossover GP II, LLC | 7,915,567 6.900% | 7,915,567 (New Position) | Filing History |
| 2026-02-06 4:42 pm Purchase | 2026-01-30 | 13G | ALX ONCOLOGY HLDGS INC ALXO | TCG Crossover GP II, LLC | 13,011,849 9.900% | 13,011,849 (New Position) | Filing History |
| 2026-02-02 4:13 pm Purchase | 2026-01-26 | 13G | SURROZEN INC SRZN | TCG Crossover GP II, LLC | 1,274,010 11.400% | 1,274,010 (New Position) | Filing History |
| 2026-01-15 4:19 pm Purchase | 2026-01-09 | 13G | CENTURY THERAPEUTICS INC IPSC | TCG Crossover GP II, LLC | 17,754,430 9.900% | 17,754,430 (New Position) | Filing History |